Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-02-18
1988-04-26
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514290, 514291, 514863, A61K 3144
Patent
active
047405112
ABSTRACT:
A method of treating hyperproliferative skin disease with substituted quinoline, [1,5]- and [1,8]- naphthyridine and pyrido[2,3-b]pyrazine derivatives is disclosed. The compounds are also anti-allergic, anti-inflammatory and cytoprotective agents. Methods for their preparation and use are disclosed.
REFERENCES:
patent: 4113731 (1978-09-01), Winters et al.
patent: 4232017 (1980-11-01), Winters et al.
patent: 4452800 (1984-06-01), Sherlock
patent: 4680298 (1987-07-01), Blythin
Billups Richard C.
Miller Stephen I.
Nelson James R.
Schenkman Leonard
Schering Corporation
LandOfFree
Method of treating hyperproliferative skin disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hyperproliferative skin disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperproliferative skin disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-819787